Get the Stockscreener App
1.87
6.03%
-0.12
After Hours:
1.87
Goodrx Holdings Inc stock is traded at $1.87, with a volume of 6.06M.
It is down -6.03% in the last 24 hours and down -19.74% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$1.99
Open:
$1.99
24h Volume:
6.06M
Relative Volume:
2.27
Market Cap:
$634.74M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-14.10
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-24.29%
1M Performance:
-19.74%
6M Performance:
-58.44%
1Y Performance:
-62.45%
1-Day Range:
$1.7901
$1.99
1-Week Range:
$1.7901
$2.4894
52-Week Range:
$1.7901
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
1.87 | 675.47M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
182.01 | 30.06B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.25 | 9.91B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
41.43 | 7.24B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.49 | 6.61B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.65 | 4.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Dec-09-25 | Initiated | Barclays | Underweight |
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Leerink cuts GoodRx stock price target to $3 on weak guidance - Investing.com UK
GoodRx Holdings Inc. (GDRX) PT Lowered to $3 at Leerink Partners - StreetInsider
GoodRx (NASDAQ:GDRX) Sets New 52-Week LowHere's What Happened - MarketBeat
GDRX: Pharma Direct revenue surged 41% in 2025, driving growth amid evolving healthcare trends - TradingView
Earnings call transcript: GoodRx Q4 2025 revenue meets expectations amid strategic shifts - Investing.com
GDRX: Pharma Direct and subscriptions drive growth amid near-term revenue pressure and strategic shifts - TradingView
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings - Yahoo Finance
GoodRx Reports Fourth Quarter and Full Year 2025 Results - PharmiWeb.com
GoodRx (GDRX) Sees High Call Activity Ahead of Earnings - GuruFocus
GoodRx (NASDAQ:GDRX) Announces Earnings Results - MarketBeat
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q4 EPS ; Offers Guidance - StreetInsider
GoodRx Holdings options imply 10.2% move in share price post-earnings - TipRanks
GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring A Potential 100% Upside - DirectorsTalk Interviews
Employers get new way to cut Wegovy and GLP-1 costs with GoodRx - Stock Titan
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect - Finviz
GoodRx (GDRX) Projected to Post Earnings on Wednesday - MarketBeat
GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
LSV Asset Management Boosts Stock Position in GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 11% Loss Last Week Hit Both Individual Investors Who Own 48% as Well as Institutions - 富途牛牛
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GoodRx Holdings, Inc. (NASDAQ: GDRX) and Encourages Long-Term GDRX Investors to Contact the Firm - ACCESS Newswire
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX) - Yahoo Finance
GoodRx (NASDAQ:GDRX) Trading Up 7.9%Should You Buy? - MarketBeat
GoodRx (NASDAQ:GDRX) Trading Down 6.4%Should You Sell? - MarketBeat
GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth - MSN
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy? - Yahoo Finance
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) biggest owners are retail investors who got richer after stock soared 7.5% last week - simplywall.st
GoodRx (GDRX) Partners with Pfizer for Discounts on TrumpRx - GuruFocus
Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from Jefferies - Insider Monkey
GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx - Seeking Alpha
GoodRx Says It's Key Integration Partner for TrumpRx Platform; Shares Up Pre-Bell - marketscreener.com
11 Best Stocks Under $3 to Buy Right Now - Insider Monkey
Pfizer cuts prices up to 85% on 30+ drugs via TrumpRx and GoodRx - Stock Titan
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - Yahoo Finance
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - The Motley Fool
GoodRx powers pricing for leading Brand Medications on TrumpRX - marketscreener.com
GoodRx stock climbs amid TrumpRx launch speculation By Investing.com - Investing.com Canada
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Is A 100% Upside Within Reach? - DirectorsTalk Interviews
GoodRx (GDRX) to Offer Savings on Arakoda in New Partnership - GuruFocus
GoodRx system that saved Americans $100B earns key data safety seal - Stock Titan
Risk Report: Can GoodRx Holdings Inc expand its profit marginsQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Published on: 2026-01-30 09:08:15 - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.04 Million in GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - Caledonian Record
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring An 80% Upside Potential - DirectorsTalk Interviews
Is GoodRx Holdings Inc. showing insider buyingWeekly Investment Summary & Long-Term Safe Investment Ideas - mfd.ru
GoodRx (NASDAQ:GDRX) Hits New 1-Year LowShould You Sell? - MarketBeat
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Rate Hike: How does GoodRx Holdings Inc perform in inflationary periodsPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews - Benzinga
Weekly Recap: What is HBANLs revenue forecastGlobal Markets & Daily Profit Focused Stock Screening - baoquankhu1.vn
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.86%
4.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):